These findings are of particular interest given a recent report by Z. Zhu et al. that showed that invasive prostate cancer with bone metastasis exhibited higher BTK expression than non-invasive prostate cancer or benign prostatic hyperplasia. Here, BTK is linked to prostate carcinoma.